<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00580502</url>
  </required_header>
  <id_info>
    <org_study_id>H # 10686</org_study_id>
    <secondary_id>10686</secondary_id>
    <secondary_id>G030190</secondary_id>
    <nct_id>NCT00580502</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of Adjustable Gastric Band Operations for Patients With Body Mass Index (BMI) Between 30-40 kg/m2</brief_title>
  <acronym>LBMI</acronym>
  <official_title>A Prospective Study to Evaluate the Safety and Efficacy of LAP-BAND® Adjustable Gastric Band (LAGB®) Operations for Patients With BMI Between 30-40 kg/m2 With Co-morbidities</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>New York University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Allergan</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>New York University School of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is to evaluate the safety and efficacy of Gastric Banding for patients with body
      mass index (BMI) between 30-40 kg/m2 with medical conditions related to obesity.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      TITLE OF STUDY:A prospective study to evaluate the safety and efficacy of LAP-BAND®
      Adjustable Gastric Band (LAGB®) operations for patients with BMI between 30-40 kg/m2 with
      co-morbidities

      CLINICAL PHASE: Phase III new indication for use of the device not yet approved by FDA

      STUDY OBJECTIVES

        -  To determine the safety and efficacy of the LAP-BAND® Adjustable Gastric Band (LAGB®)
           for patients with BMI between 30-40 kg/m2 with co-morbidities

        -  To determine long-term effects on patients' co-morbidities

      STUDY VARIABLES: Morbidity &amp; mortality, percent of excess weight loss, nutritional status,
      improvement of pre-operative co-morbidities, weight loss maintained, and quality of life
      evaluation

      DESIGN: Prospective single center study
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2004</start_date>
  <completion_date type="Actual">September 2012</completion_date>
  <primary_completion_date type="Actual">September 2012</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To Determine Percent of Excess Weight Loss (%EWL) After Laparoscopic Adjustable Gastric Banding Surgery</measure>
    <time_frame>5 years</time_frame>
    <description>Change in weight from baseline at 5 years by calculating the percentage of the weight loss from the total excess weight.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Level of LDL (Bad Cholesterol) After Laparoscopic Adjustable Gastric Band Surgery</measure>
    <time_frame>5 years</time_frame>
    <description>Change in level of LDL from baseline at 5 years</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Level of Triglycerides (Bad Cholesterol) After Laparoscopic Adjustable Gastric Band Surgery</measure>
    <time_frame>5 years</time_frame>
    <description>Change in level of Triglycerides from baseline at 5 years</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Level of HbA1c (Blood Test for Diabetes) After Laparoscopic Adjustable Gastric Band Surgery</measure>
    <time_frame>5 years</time_frame>
    <description>Change in level of HbA1c from baseline at 5 years</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>LAGB for low BMI patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>the LAP-BAND® Adjustable Gastric Band (LAGB®) for patients with BMI between 30-40 kg/m2 with co-morbidities</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>LAP-BAND® Adjustable Gastric Band (LAGB®)</intervention_name>
    <description>Bariatric surgery for patient whose BMI is between 30 and 40 kg/m^2</description>
    <arm_group_label>LAGB for low BMI patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Be at least 18 and equal to or less than 60 years of age.

          -  BMI of at least 30 and maximum BMI of 40 with co-morbidities

          -  Willingness to comply with dietary restrictions required by the protocol

          -  History of obesity for at least 5 years

          -  History of at least 6 months of documented failures with traditional non-surgical
             weight loss methods

          -  Willingness to follow protocol requirements

          -  If female with childbearing potential, using an appropriate form of contraception

        Exclusion Criteria:

          -  Age less than 18, age greater than 60

          -  Pregnancy

          -  History of major depressive disorder or psychosis

          -  Previous bariatric surgery or previous gastric surgery

          -  Presence of achalasia

          -  Presence of portal hypertension, cirrhosis, and/or varices

          -  Patient with inflammatory disease of the gastrointestinal tract such as Crohn's
             Disease

          -  Patients with autoimmune connective tissue disorders

          -  Patients with acute abdominal infections

          -  Any condition that, in the judgment of the investigator, would place a subject at
             undue risk, or potentially compromise the results or interpretation of the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christine Ren-Fielding, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>NYUSOM</affiliation>
  </overall_official>
  <link>
    <url>http://nyuweightloss.org</url>
    <description>NYU Program for Surgical Weight Loss</description>
  </link>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 21, 2007</study_first_submitted>
  <study_first_submitted_qc>December 21, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 24, 2007</study_first_posted>
  <results_first_submitted>December 29, 2014</results_first_submitted>
  <results_first_submitted_qc>March 16, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">March 23, 2015</results_first_posted>
  <last_update_submitted>March 16, 2015</last_update_submitted>
  <last_update_submitted_qc>March 16, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 23, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>New York University School of Medicine</investigator_affiliation>
    <investigator_full_name>Heekoung A Youn</investigator_full_name>
    <investigator_title>Research coordinator</investigator_title>
  </responsible_party>
  <keyword>Obesity, 50 lbs overweight</keyword>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Lap-Band</title>
          <description>Low BMI patients who will go through Lap-band surgery.
LAP-BAND® Adjustable Gastric Band (LAGB®): Bariatric surgery: LAGB</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="50"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="50"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>LAP-BAND® Adjustable Gastric Band (LAGB®) Operations</title>
          <description>A prospective study to evaluate the safety and efficacy of LAP-BAND® Adjustable Gastric Band (LAGB®) operations for patients with BMI between 30-40 kg/m2 with co-morbidities</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="50"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>BMI</title>
          <units>kg/m2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35.1" spread="2.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>To Determine Percent of Excess Weight Loss (%EWL) After Laparoscopic Adjustable Gastric Banding Surgery</title>
        <description>Change in weight from baseline at 5 years by calculating the percentage of the weight loss from the total excess weight.</description>
        <time_frame>5 years</time_frame>
        <population>All participants who underwent LAGB are included in the analysis population.</population>
        <group_list>
          <group group_id="O1">
            <title>LAGB</title>
            <description>LAGB surgery for the patient whose BMI between 30 and 40 kg/m^2</description>
          </group>
        </group_list>
        <measure>
          <title>To Determine Percent of Excess Weight Loss (%EWL) After Laparoscopic Adjustable Gastric Banding Surgery</title>
          <description>Change in weight from baseline at 5 years by calculating the percentage of the weight loss from the total excess weight.</description>
          <population>All participants who underwent LAGB are included in the analysis population.</population>
          <units>percentage of excess weight loss</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51.74" spread="27.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Level of LDL (Bad Cholesterol) After Laparoscopic Adjustable Gastric Band Surgery</title>
        <description>Change in level of LDL from baseline at 5 years</description>
        <time_frame>5 years</time_frame>
        <population>All participants who underwent LAGB are included in the analysis population.</population>
        <group_list>
          <group group_id="O1">
            <title>LAGB</title>
            <description>LAGB surgery for the patient whose BMI between 30 and 40 kg/m^2</description>
          </group>
        </group_list>
        <measure>
          <title>Level of LDL (Bad Cholesterol) After Laparoscopic Adjustable Gastric Band Surgery</title>
          <description>Change in level of LDL from baseline at 5 years</description>
          <population>All participants who underwent LAGB are included in the analysis population.</population>
          <units>mg/dl</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="117" spread="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Level of Triglycerides (Bad Cholesterol) After Laparoscopic Adjustable Gastric Band Surgery</title>
        <description>Change in level of Triglycerides from baseline at 5 years</description>
        <time_frame>5 years</time_frame>
        <population>All participants who underwent LAGB and had 5 year follow up visit are included in the analysis population.</population>
        <group_list>
          <group group_id="O1">
            <title>LAGB</title>
            <description>LAGB surgery for the patient whose BMI between 30 and 40 kg/m^2</description>
          </group>
        </group_list>
        <measure>
          <title>Level of Triglycerides (Bad Cholesterol) After Laparoscopic Adjustable Gastric Band Surgery</title>
          <description>Change in level of Triglycerides from baseline at 5 years</description>
          <population>All participants who underwent LAGB and had 5 year follow up visit are included in the analysis population.</population>
          <units>mg/dl</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="103" spread="58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Level of HbA1c (Blood Test for Diabetes) After Laparoscopic Adjustable Gastric Band Surgery</title>
        <description>Change in level of HbA1c from baseline at 5 years</description>
        <time_frame>5 years</time_frame>
        <population>All participants who underwent LAGB and had 5 year f/u visit are included in the analysis population.</population>
        <group_list>
          <group group_id="O1">
            <title>LAGB</title>
            <description>LAGB surgery for the patient whose BMI between 30 and 40 kg/m^2</description>
          </group>
        </group_list>
        <measure>
          <title>Level of HbA1c (Blood Test for Diabetes) After Laparoscopic Adjustable Gastric Band Surgery</title>
          <description>Change in level of HbA1c from baseline at 5 years</description>
          <population>All participants who underwent LAGB and had 5 year f/u visit are included in the analysis population.</population>
          <units>percentage of HbA1c</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.6" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Entire 5 years study period</time_frame>
      <group_list>
        <group group_id="E1">
          <title>LAP-BAND® Adjustable Gastric Band (LAGB®) Operations</title>
          <description>A prospective study to evaluate the safety and efficacy of LAP-BAND® Adjustable Gastric Band (LAGB®) operations for patients with BMI between 30-40 kg/m2 with co-morbidities</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Band revision/replacement</sub_title>
                <counts group_id="E1" events="14" subjects_affected="14" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Port revision/replacement</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Heekoung Youn</name_or_title>
      <organization>NYULMC</organization>
      <phone>2122632174</phone>
      <email>younh01@nyumc.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

